Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan A Smith

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Plos One|May 7, 2020
The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling studyMichaela T Hall, Megan A Smith, Kate T Simms, et al.
BMC Health Services Research|April 27, 2016
Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource useMegan A Smith, Dorota Gertig, Michaela Hall, et al.
Journal of Medical Screening|July 19, 2023
Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up studySusan Yuill, Sam Egger, Megan A Smith, et al.
BMC Public Health|March 21, 2026
Qualitative insights into the acceptability of self-collection for cervical screening amongst under- and never-screened groups in AustraliaPaula Jops, Alegra Wolter, Claire Bavor, et al.
The Lancet. Public Health|February 15, 2020
Projected time to elimination of cervical cancer in the USA: a comparative modelling studyEmily A Burger, Megan A Smith, James Killen, et al.
The Lancet. Public Health|December 19, 2017
Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysisKate T Simms, Jean-François Laprise, Megan A Smith, et al.
Journal of the American Society of Cytopathology|May 3, 2019
Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programsMegan A Smith, Julia M L Brotherton, Ian G Hammond, et al.
Gynecologic Oncology|March 17, 2019
The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implicationsMichaela T Hall, Megan A Smith, Jie-Bin Lew, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 29, 2021
Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologistsHelena M Obermair, Kirsty F Bennett, Julia M L Brotherton, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 13, 2025
Participation in the National Cervical Screening Program Among Women Who Gave Birth in New South Wales, Australia by Place of Maternal Birth: A Data Linkage AnalysisSusan Yuill, Megan A Smith, Louiza S Velentzis, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Plos One|May 7, 2020
The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling studyMichaela T Hall, Megan A Smith, Kate T Simms, et al.
BMC Health Services Research|April 27, 2016
Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource useMegan A Smith, Dorota Gertig, Michaela Hall, et al.
Journal of Medical Screening|July 19, 2023
Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up studySusan Yuill, Sam Egger, Megan A Smith, et al.
BMC Public Health|March 21, 2026
Qualitative insights into the acceptability of self-collection for cervical screening amongst under- and never-screened groups in AustraliaPaula Jops, Alegra Wolter, Claire Bavor, et al.
The Lancet. Public Health|February 15, 2020
Projected time to elimination of cervical cancer in the USA: a comparative modelling studyEmily A Burger, Megan A Smith, James Killen, et al.
The Lancet. Public Health|December 19, 2017
Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysisKate T Simms, Jean-François Laprise, Megan A Smith, et al.
Journal of the American Society of Cytopathology|May 3, 2019
Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programsMegan A Smith, Julia M L Brotherton, Ian G Hammond, et al.
Gynecologic Oncology|March 17, 2019
The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implicationsMichaela T Hall, Megan A Smith, Jie-Bin Lew, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 29, 2021
Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologistsHelena M Obermair, Kirsty F Bennett, Julia M L Brotherton, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 13, 2025
Participation in the National Cervical Screening Program Among Women Who Gave Birth in New South Wales, Australia by Place of Maternal Birth: A Data Linkage AnalysisSusan Yuill, Megan A Smith, Louiza S Velentzis, et al.
Pageof 10